HLS Therapeutics to Announce Q3 2024 Financial Results
Company Announcements

HLS Therapeutics to Announce Q3 2024 Financial Results

Story Highlights

HLS Therapeutics Inc (TSE:HLS) has released an update.

HLS Therapeutics Inc. is set to release its Q3 fiscal 2024 financial results on November 7, 2024, with a conference call to follow discussing the results. The company, which specializes in pharmaceutical products for psychiatric disorders and cardiovascular disease, continues to focus on North American markets.

For further insights into TSE:HLS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskHLS Therapeutics to Present at Global Investment Conference
TipRanks Canadian Auto-Generated NewsdeskHLS Therapeutics Reports Mixed Q2 Results and Strategic Sales
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App